Pharma Partnerships Strategic pharma collaborations are already central to Trellus Health, with renewed Pfizer licensing for the Elevate platform and a Johnson & Johnson partnership. These relationships validate the value of resilience-first digital care in chronic disease and open a scalable pathway to license or co-develop patient engagement solutions across additional therapies and indications.

Clinical Trial Expansion Expansion into clinical trial networks is underway via a master services agreement with Gastro Health Group for TrialSet engagement tools, indicating demand for standardized patient engagement and retention tooling across sites. This creates opportunities to offer TrialSet more broadly to CRO networks and other trial sites, with potential upsell to large sponsor programs.

Employer Value The platform’s potential to reduce healthcare costs and improve outcomes presents a compelling ROI case for corporate wellness programs and payer-led disease management initiatives. Sales opportunities include direct employer deployments, wellness program integrations, and value-based care contracts.

Platform Fit Trellus Elevate is a tech-enabled solution with connectivity to common healthcare IT and operations stacks, enabling smoother adoption by clinics, health systems, or employer-based programs. Opportunities include EHR integrations, site-network expansions, and joint go-to-market efforts with system integrators.

Growth Traction Recent strategic partnerships, client wins, and leadership developments signal growth potential that can be leveraged to engage growth-focused investors, strategic partners, and healthcare providers seeking to scale digital chronic-disease programs with resilience-driven care.